Search
Briacell Therapeutics Corp
BCTXAdd to Watchlist
3.440USD
-0.190-5.23%
Close 07-31 16:00（ET）Quotes delayed by 15 min
24.94MMarket Cap
LossP/E TTM
Briacell Therapeutics Corp's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Briacell Therapeutics Corp is 7.50, ranking 168 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.24, which is -14333783.07% below the recent high of 34214.50 and -42998.87% above the recent low of -102.88.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.